THE MODERN BIO← All tests

MODERN BIO / TESTING LAB / BLOOD & BIOMARKERS

Useful in context

TEST PASSPORT · REVIEWED JULY 2026

Sex hormone evaluation

Match the test, timing and reference context to the actual symptom and life stage.

Testosterone, estradiol, SHBG, LH, FSH and prolactin answer different questions. Random mega-panels create noise; a staged evaluation is more defensible.

Blood & biomarkers diagnostic testing visualization
HORMONE PANEL / DECISION GUIDE
ACCESSLab drawVenous blood
TURNAROUNDOften 2–7 daysProvider and location dependent
RELATIVE COST$$–$$$Total downstream cost matters
COMMERCE STATUSClinician pathwayStaged lab order + licensed-clinician review

HOW TO USE THIS PAGE

Decide whether this test deserves a place in your plan.

  1. 01
    Confirm the question

    Be clear about what decision the result would change before ordering.

  2. 02
    Check fit and preparation

    Review who it helps, who should pause and how to protect the quality of the signal.

  3. 03
    Plan the response

    Know what you will do with a normal, abnormal or unclear result.

01 / WHO SHOULD TAKE IT

Fit the test to
the person.

Testing is useful when the result can change a real decision. These are educational selection criteria, not a diagnosis or personal order.
GOOD-FIT QUESTIONS
  • People with persistent sexual, menstrual, fertility or hypogonadal symptoms
  • People considering or monitoring clinician-prescribed hormone therapy
  • People with pituitary, gonadal or menopause-related questions
PAUSE BEFORE ORDERING
  • Starting testosterone, estrogen or ‘boosters’ from one online result
  • Applying the same timing and reference context to everyone

02 / SIGNAL VS. STORY

What it tells you.
What it cannot.

THE SIGNAL
01

Total hormone concentration and binding context

02

Pituitary signals such as LH/FSH

03

Patterns that guide confirmatory testing or specialist review

THE LIMIT
01

Sleep, energy balance, illness, medications and timing can strongly affect results

02

Symptoms do not map cleanly to one hormone value

03

Fertility and sexual function require broader assessment

03 / MARKERS + RANGES

Read the panel
without chasing flags.

The report should show its own method, units and laboratory reference interval. Clinical decision thresholds may be different from a lab interval. We do not invent a universal “optimal” range where authoritative guidance does not support one.
01Total testosterone

Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.

02SHBG + calculated free testosterone when appropriate

Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.

03Estradiol

Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.

04LH / FSH

Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.

05Prolactin

Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.

06Pregnancy or cycle-specific tests when relevant

Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.

MEN, WOMEN + LIFE-STAGE CONTEXT

The correct range is personal context—not pink versus blue numbers.

Where biology differs, we call it out. Clinical interpretation should also reflect organs present, hormone therapy, pregnancy, age, medications and health history.

Women

Cycle phase, contraception, pregnancy, perimenopause and menopause are essential; a single ‘normal female range’ is inadequate.

Men

Low testosterone diagnosis generally requires compatible symptoms plus consistently low morning values and evaluation of the cause.

04 / PREPARATION

Protect the quality
of the signal.

The best assay cannot rescue the wrong timing, wrong specimen or wrong question. Follow the ordering clinician and laboratory instructions when they differ from this general guide.
01Timing

Testosterone is commonly confirmed with morning draws; cycle-dependent tests need planned timing.

02Repeat

Unexpected or treatment-changing results usually require confirmation.

03Medication

Record contraception, HRT/TRT, fertility medicines, steroids, opioids and supplements.

REPEAT CADENCESymptom- and treatment-based. Monitoring intervals depend on the therapy, dose, route, risk and clinical guideline.

05 / AFTER THE RESULT

Turn the number
into a next step.

  1. 01

    Confirm the result under standardized conditions

  2. 02

    Separate symptom treatment from fertility goals

  3. 03

    Review hematocrit, blood pressure and other therapy-specific safety measures where applicable

DO NOT WAIT ON A CONSUMER TEST

Severe headache with vision change

Testicular mass, postmenopausal bleeding or pregnancy concerns need prompt clinical care

Chest pain or acute shortness of breath on hormone therapy

06 / MODERN BIO SELECT

Built for a responsible purchase path.

Commerce must include ordering oversight, confirmatory testing and a no-pressure treatment policy.
CLINICIAN PATHWAY

Sex hormone evaluation

Future format
Staged lab order + licensed-clinician review
Price position
Future hormone pathway
Before checkout
Eligibility · method · privacy · total cost · interpretation · abnormal-result routing
Join product early access →

07 / SCIENTIFIC FOUNDATION

Open the source.
Check the claim.

We prefer official guidance, clinical standards and primary scientific records. A source supports the specific point described on this passport—not every marketing use of the test.